| Ingela Liz Helen Danielsson-sanden, MD | |
|
301 W Expressway 83, Mcallen, TX 78503-3045 | |
| (956) 632-4000 | |
| (956) 961-4286 |
| Full Name | Ingela Liz Helen Danielsson-sanden |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 301 W Expressway 83, Mcallen, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033346630 | NPI | - | NPPES |
| 3520876-01 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | N5003 (Texas) | Primary |
| 2084N0400X | Psychiatry & Neurology - Neurology | D0054165 (Maryland) | Secondary |
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
In a new study led by the Immune Systems Biology research group of the LIH Department of Infection and Immunity, researchers adopted a holistic machine-learning approach to elucidate how the interactions between neuronal mitochondria can serve as a powerful tool to distinguish nerve cells from Parkinson's patients from those belonging to healthy subjects, thereby providing new insights in the pathogenesis, diagnosis and treatment of this neurodegenerative disorder.
Noting there are "less than 1,000 days until the 2015 deadline for the Millennium Development Goals," Zach Silberman, a policy associate with the U.S. Global Leadership Coalition, writes in the coalition's blog, "One thing is for certain: the MDGs galvanized the global community to work together towards improving the lives of those in the developing world and represent a significant step towards a more global approach to development."
Advances in medical therapy have improved outcomes for many ambulatory patients with heart failure and low ejection fraction (EF; a measure of how much blood the left ventricle of the heart pumps out with each contraction), according to background information in the article.
It is common knowledge that as people grow older they lose a large part of their muscle mass - and neither are their bones what they once were. Researchers from Aarhus University, Denmark, working together with researchers at Erasmus Medical Center in Rotterdam have now studied a new group of medication which could prove beneficial for the elderly and the chronically ill who suffer a loss of bone- and muscle mass.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
› Verified 4 days ago
| Entity Name | Mcallen Hospitalist Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356361976 PECOS PAC ID: 9830113836 Enrollment ID: O20060117001076 |
News Archive
In a new study led by the Immune Systems Biology research group of the LIH Department of Infection and Immunity, researchers adopted a holistic machine-learning approach to elucidate how the interactions between neuronal mitochondria can serve as a powerful tool to distinguish nerve cells from Parkinson's patients from those belonging to healthy subjects, thereby providing new insights in the pathogenesis, diagnosis and treatment of this neurodegenerative disorder.
Noting there are "less than 1,000 days until the 2015 deadline for the Millennium Development Goals," Zach Silberman, a policy associate with the U.S. Global Leadership Coalition, writes in the coalition's blog, "One thing is for certain: the MDGs galvanized the global community to work together towards improving the lives of those in the developing world and represent a significant step towards a more global approach to development."
Advances in medical therapy have improved outcomes for many ambulatory patients with heart failure and low ejection fraction (EF; a measure of how much blood the left ventricle of the heart pumps out with each contraction), according to background information in the article.
It is common knowledge that as people grow older they lose a large part of their muscle mass - and neither are their bones what they once were. Researchers from Aarhus University, Denmark, working together with researchers at Erasmus Medical Center in Rotterdam have now studied a new group of medication which could prove beneficial for the elderly and the chronically ill who suffer a loss of bone- and muscle mass.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ingela Liz Helen Danielsson-sanden, MD Po Box 843204, Dallas, TX 75284-3204 Ph: (484) 913-7434 | Ingela Liz Helen Danielsson-sanden, MD 301 W Expressway 83, Mcallen, TX 78503-3045 Ph: (956) 632-4000 |
News Archive
In a new study led by the Immune Systems Biology research group of the LIH Department of Infection and Immunity, researchers adopted a holistic machine-learning approach to elucidate how the interactions between neuronal mitochondria can serve as a powerful tool to distinguish nerve cells from Parkinson's patients from those belonging to healthy subjects, thereby providing new insights in the pathogenesis, diagnosis and treatment of this neurodegenerative disorder.
Noting there are "less than 1,000 days until the 2015 deadline for the Millennium Development Goals," Zach Silberman, a policy associate with the U.S. Global Leadership Coalition, writes in the coalition's blog, "One thing is for certain: the MDGs galvanized the global community to work together towards improving the lives of those in the developing world and represent a significant step towards a more global approach to development."
Advances in medical therapy have improved outcomes for many ambulatory patients with heart failure and low ejection fraction (EF; a measure of how much blood the left ventricle of the heart pumps out with each contraction), according to background information in the article.
It is common knowledge that as people grow older they lose a large part of their muscle mass - and neither are their bones what they once were. Researchers from Aarhus University, Denmark, working together with researchers at Erasmus Medical Center in Rotterdam have now studied a new group of medication which could prove beneficial for the elderly and the chronically ill who suffer a loss of bone- and muscle mass.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
› Verified 4 days ago
Abdo Gonzalez Silvera, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 W Expressway 83, Mcallen, TX 78503 Phone: 956-632-4000 Fax: 956-961-4286 | |
Claudia Patricia Akcoban, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 W Expressway 83, Mcallen, TX 78503 Phone: 956-632-4000 Fax: 956-961-4286 | |
Shwe Yee Win, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 W Expressway 83, Mcallen, TX 78503 Phone: 956-632-4000 Fax: 956-961-4286 | |
Dr. Abraham Campoy, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 W Expressway 83, Mcallen, TX 78503 Phone: 956-632-4000 Fax: 956-961-4286 | |
Dr. Carmen Maureen Gomez Fitzpatrick, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 W Expressway 83, Mcallen, TX 78503 Phone: 956-632-4000 Fax: 956-961-4286 | |
Dr. Luis G San Miguel, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 W Expressway 83, Mcallen, TX 78503 Phone: 956-632-4000 Fax: 956-961-4286 |